Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Execution is the theme this morning, as a cluster of emerging growth stocks move from pilot programs and strategic roadmaps into operational scale.
-
Kraig Biocraft Laboratories (OTCQB: KBLB) announced that its 2026 production plan has officially moved from strategy to execution.
-
Kraig Labs (OTCQB: KBLB) is entering a new phase of commercial scale-up as it accelerates spider silk production to meet growing demand from global brands.
-
As AI continues to move beyond software and automation, its impact on genomics and gene editing is becoming increasingly tangible
-
Kraig Labs (OTCQB: KBLB) 2026 production plan will drive explosive growth and establish a new global benchmark for spider silk manufacturing.
-
Innovation still rules, but ownership of the entire supply-chain pipeline is becoming the next biggest strategic advantage in today’s markets.
-
President Trump wants to deploy AI systems to hunt fraud, likened in headlines to an AI “Ironman suit”, reigniting interest in advanced technologies
-
CRISPR and related genome engineering technologies are reshaping industries from medicine to materials, with breakthroughs
-
Materials are making plenty of noise, as Vulcan Materials (NYSE: VMC) and Applied Materials (NASDAQ: AMAT) set new 52-week highs
-
Kraig Labs (OTCQB: KBLB) is implementing its most ambitious and advanced genetic engineering initiative ever, to dramatically increase toughness